These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 21126403)
1. [The relationship between expressions of β-catenin and TCF-4 in non-small cell lung cancer]. Wang Y; Liu N; Dai S; Xu H; Wang E Zhongguo Fei Ai Za Zhi; 2007 Oct; 10(5):370-5. PubMed ID: 21126403 [TBL] [Abstract][Full Text] [Related]
2. [Expression and mutation of β-catenin in non-small cell lung cancer]. Xu H; Lin D; Wang L; Liu N; Wang E Zhongguo Fei Ai Za Zhi; 2004 Oct; 7(5):409-13. PubMed ID: 21244793 [TBL] [Abstract][Full Text] [Related]
3. Abnormal beta-catenin and reduced axin expression are associated with poor differentiation and progression in non-small cell lung cancer. Xu HT; Wang L; Lin D; Liu Y; Liu N; Yuan XM; Wang EH Am J Clin Pathol; 2006 Apr; 125(4):534-41. PubMed ID: 16627264 [TBL] [Abstract][Full Text] [Related]
4. [Expression of E-cadherin and β-catenin and their significance in non-small cell lung cancer]. Yan H; Jiang Y; Zhang H; Chen X; Ma Y; Wang C Zhongguo Fei Ai Za Zhi; 2005 Jun; 8(3):202-6. PubMed ID: 21190620 [TBL] [Abstract][Full Text] [Related]
5. [Expressions of Frat and beta-catenin in lung cancer and their clinicopathological correlations.]. Luan L; Zhang Y; Guo N; Wang E Zhongguo Fei Ai Za Zhi; 2008 Feb; 11(1):62-6. PubMed ID: 20727269 [TBL] [Abstract][Full Text] [Related]
6. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer]. Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of axin downregulates TCF-4 and inhibits the development of lung cancer. Xu HT; Wei Q; Liu Y; Yang LH; Dai SD; Han Y; Yu JH; Liu N; Wang EH Ann Surg Oncol; 2007 Nov; 14(11):3251-9. PubMed ID: 17768662 [TBL] [Abstract][Full Text] [Related]
8. [Transfection of Axin Gene Down-regulates Expressions of beta-catenin and TCF-4 and Inhibits the Proliferation and Invasive Ability of Lung Cancer Cells.]. Liu S; Xu H; Yang L; Li Q; Wei Q; Wang E Zhongguo Fei Ai Za Zhi; 2009 Apr; 12(4):277-82. PubMed ID: 20719112 [TBL] [Abstract][Full Text] [Related]
9. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis]. Tang XJ; Zhou QH; Zhang SF; Liu LX Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109 [TBL] [Abstract][Full Text] [Related]
10. [Expressions of Axin and beta-catenin in non-small cell lung cancer]. Xu HT; Wang L; Lin D; Liu Y; Liu N; Wang EH Zhonghua Bing Li Xue Za Zhi; 2005 Aug; 34(8):519-23. PubMed ID: 16383300 [TBL] [Abstract][Full Text] [Related]
11. [Distribution and mRNA expression of β-catenin in non-small-cell lung cancer]. Li C; Wang E Zhongguo Fei Ai Za Zhi; 2004 Feb; 7(1):27-30. PubMed ID: 21211187 [TBL] [Abstract][Full Text] [Related]
12. gamma-Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth. Winn RA; Bremnes RM; Bemis L; Franklin WA; Miller YE; Cool C; Heasley LE Oncogene; 2002 Oct; 21(49):7497-506. PubMed ID: 12386812 [TBL] [Abstract][Full Text] [Related]
13. The expression patterns and correlations of chibby, β-catenin, and DNA methyltransferase-1 and their clinicopathological significance in lung cancers. Xu HT; Li QC; Dai SD; Xie XM; Liu DI; Wang EH APMIS; 2011 Nov; 119(11):750-8. PubMed ID: 21995627 [TBL] [Abstract][Full Text] [Related]
14. [Abnormal Expression of p120-catenin and E-cadherin Is Significantly Correlated with Malignant Phenotype of Human Lung Cancer.]. Wang M; Liu Y; Liu S; Wang E Zhongguo Fei Ai Za Zhi; 2009 Apr; 12(4):306-11. PubMed ID: 20719116 [TBL] [Abstract][Full Text] [Related]
15. Expression of T cell factor-4 in non-small-cell lung cancer. Li CY; Wang Y; Cui ZS; Wang EH Chin Med J (Engl); 2005 Jan; 118(2):136-40. PubMed ID: 15667799 [TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer. Relation to clinicopathological factors, beta-catenin and prognosis. Leinonen T; Pirinen R; Böhm J; Johansson R; Ropponen K; Kosma VM Lung Cancer; 2006 Mar; 51(3):313-21. PubMed ID: 16423426 [TBL] [Abstract][Full Text] [Related]
17. Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex. Huang L; Shitashige M; Satow R; Honda K; Ono M; Yun J; Tomida A; Tsuruo T; Hirohashi S; Yamada T Gastroenterology; 2007 Nov; 133(5):1569-78. PubMed ID: 17983804 [TBL] [Abstract][Full Text] [Related]
18. The value of E-cadherin/beta-catenin expression in imprints of NCSLC: relationship with clinicopathological factors. Pagaki E; Patsouris E; Gonidi M; Athanassiadou AM; Maurikakis M; Athanassiades P; Chelidonis G; Athanassiadou P Diagn Cytopathol; 2010 Jun; 38(6):419-24. PubMed ID: 20474081 [TBL] [Abstract][Full Text] [Related]
19. [High expression of TCF-4 positively correlated with lung cancer progression.]. Yang L; Xu H; Wang Y; Liu Y; Zhao Y; Dai S; Wei Q; Miao Y; Han Y; Yang Z; Liu N; Wang E Zhongguo Fei Ai Za Zhi; 2008 Apr; 11(2):214-9. PubMed ID: 20731904 [TBL] [Abstract][Full Text] [Related]
20. [Expression and its significance of Pin1 and β-catenin in squamous cell carcinoma and adenocarcinoma of the lung]. Cao W; Zhang D; Qiao J; Fang C; Hou R Zhongguo Fei Ai Za Zhi; 2006 Oct; 9(5):418-22. PubMed ID: 21176462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]